Literature DB >> 35505049

Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.

Tapan Behl1, Sachin Kumar2, Ziyad M Althafar3, Aayush Sehgal2, Sukhbir Singh2, Neelam Sharma2, Vishnu Nayak Badavath2, Shivam Yadav4, Saurabh Bhatia5,6, Ahmed Al-Harrasi5, Yosif Almoshari7, Mohannad A Almikhlafi8, Simona Bungau9.   

Abstract

Over the last decade, researchers have discovered that  a group of apparently unrelated neurodegenerative disorders, such as Parkinson's disease, have remarkable cellular and molecular biology similarities. Protein misfolding and aggregation are involved in all of the neurodegenerative conditions; as a result, inclusion bodies aggregation starts in the cells. Chaperone proteins and ubiquitin (26S proteasome's proteolysis signal), which aid in refolding misfolded proteins, are frequently found in these aggregates. The discovery of disease-causing gene alterations that code for multiple ubiquitin-proteasome pathway proteins in Parkinson's disease has strengthened the relationship between the ubiquitin-proteasome system and neurodegeneration. The specific molecular linkages between these systems and pathogenesis, on the other hand, are unknown and controversial. We outline the current level of knowledge in this article, focusing on important unanswered problems.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neurodegeneration; Parkinson's disease; Proteolysis; UPS; α-synuclein

Mesh:

Substances:

Year:  2022        PMID: 35505049     DOI: 10.1007/s12035-022-02851-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  120 in total

1.  Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

Authors:  K A Sieradzan; A O Mechan; L Jones; E E Wanker; N Nukina; D M Mann
Journal:  Exp Neurol       Date:  1999-03       Impact factor: 5.330

2.  Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.

Authors:  Qi Zhu; Xu-Xu Zhuang; Jia-Yue Chen; Ning-Ning Yuan; Yan Chen; Cui-Zan Cai; Jie-Qiong Tan; Huan-Xing Su; Jia-Hong Lu
Journal:  Phytomedicine       Date:  2021-04-27       Impact factor: 5.340

3.  Presenilin-1 mutations and Alzheimer's disease.

Authors:  Raymond J Kelleher; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-12       Impact factor: 11.205

Review 4.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

5.  Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.

Authors:  Daniel R Scoles; Pratap Meera; Matthew D Schneider; Sharan Paul; Warunee Dansithong; Karla P Figueroa; Gene Hung; Frank Rigo; C Frank Bennett; Thomas S Otis; Stefan M Pulst
Journal:  Nature       Date:  2017-04-12       Impact factor: 49.962

6.  A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

Authors:  Michael A Nalls; Raquel Duran; Grisel Lopez; Marzena Kurzawa-Akanbi; Ian G McKeith; Patrick F Chinnery; Christopher M Morris; Jessie Theuns; David Crosiers; Patrick Cras; Sebastiaan Engelborghs; Peter Paul De Deyn; Christine Van Broeckhoven; David M A Mann; Julie Snowden; Stuart Pickering-Brown; Nicola Halliwell; Yvonne Davidson; Linda Gibbons; Jenny Harris; Una-Marie Sheerin; Jose Bras; John Hardy; Lorraine Clark; Karen Marder; Lawrence S Honig; Daniela Berg; Walter Maetzler; Kathrin Brockmann; Thomas Gasser; Fabiana Novellino; Aldo Quattrone; Grazia Annesi; Elvira Valeria De Marco; Ekaterina Rogaeva; Mario Masellis; Sandra E Black; Juan M Bilbao; Tatiana Foroud; Bernardino Ghetti; William C Nichols; Nathan Pankratz; Glenda Halliday; Suzanne Lesage; Stephan Klebe; Alexandra Durr; Charles Duyckaerts; Alexis Brice; Benoit I Giasson; John Q Trojanowski; Howard I Hurtig; Nahid Tayebi; Claudia Landazabal; Melanie A Knight; Margaux Keller; Andrew B Singleton; Tyra G Wolfsberg; Ellen Sidransky
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

Review 7.  Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Authors:  Rachele A Saccon; Rosie K A Bunton-Stasyshyn; Elizabeth M C Fisher; Pietro Fratta
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

8.  Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.

Authors:  Rita Guerreiro; Valentina Escott-Price; Lee Darwent; Laura Parkkinen; Olaf Ansorge; Dena G Hernandez; Michael A Nalls; Lorraine Clark; Lawrence Honig; Karen Marder; Wiesje van der Flier; Henne Holstege; Eva Louwersheimer; Afina Lemstra; Philip Scheltens; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Sara Ortega-Cubero; Pau Pastor; Tanis J Ferman; Neill R Graff-Radford; Owen A Ross; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Walter Maetzler; Daniela Berg; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Yaroslau Compta; Tamas Revesz; Andrew Lees; Nigel J Cairns; Glenda M Halliday; David Mann; Stuart Pickering-Brown; John Powell; Katie Lunnon; Michelle K Lupton; Dennis Dickson; John Hardy; Andrew Singleton; Jose Bras
Journal:  Neurobiol Aging       Date:  2015-11-02       Impact factor: 4.673

9.  Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis.

Authors:  Su Jin Ham; Daewon Lee; Wen Jun Xu; Eunjoo Cho; Sekyu Choi; Soohong Min; Sunghyouk Park; Jongkyeong Chung
Journal:  Sci Adv       Date:  2021-07-09       Impact factor: 14.136

10.  Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease.

Authors:  Ruwani S Wijeyekoon; Sarah F Moore; Krista Farrell; David P Breen; Roger A Barker; Caroline H Williams-Gray
Journal:  Mov Disord       Date:  2020-03-04       Impact factor: 9.698

View more
  1 in total

Review 1.  Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Parkinson's disease.

Authors:  Ranran Lu; Lijie Zhang; Xinling Yang
Journal:  Front Aging Neurosci       Date:  2022-10-03       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.